Affinity of 3-acyl substituted 4-quinolones at the benzodiazepine site of GABAA receptors.

Research output: Contribution to journalArticle


The finding that alkyl 1,4-dihydro-4-oxoquinoline-3-carboxylate and N-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxamide derivatives may be high-affinity ligands at the benzodiazepine binding site of the GABAA receptor, prompted a study of 3-acyl-1,4-dihydro-4-oxoquinoline (3-acyl-4-quinolones). In general, the affinity of the 3-acyl derivatives was found to be comparable with the 3-carboxylate and the 3-carboxamide derivatives, and certain substituents (e.g., benzyl) in position 6 were again shown to be important. As it is believed that the benzodiazepine binding site is situated between an α- and a γ-subunit in the GABAA receptor, selected compounds were tested on the α1β2γ2s, α2β2γ2s and α3β2γ2s GABAA receptor subtypes. The 3-acyl-4-quinolones display various degrees of selectivity for α1- versus α2- and α3-containing receptors, and high-affinity ligands essentially selective for α1 over α3 were developed.


  • Erik Lager
  • Jakob Nilsson
  • Elsebet Østergaard Nielsen
  • Mogens Nielsen
  • Tommy Liljefors
  • Olov Sterner
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Organic Chemistry


  • 3-Acyl-1, 4-dihydro-4-oxoquinolines, Benzodiazepine binding site, GABAA receptor, GABAA receptor subtypes, Pharmacophore model
Original languageEnglish
Pages (from-to)6936-6948
JournalBioorganic & Medicinal Chemistry
Issue number14
Publication statusPublished - 2008
Publication categoryResearch

Bibliographic note

The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Organic chemistry (S/LTH) (011001240)